Sygnia Itrix ETF Streamlines Portfolio: Partial Delisting to Boost Shareholder Value

  • Sygnia Itrix MSCI Emerging Markets 50 ETF (SYGEMF) announces partial delisting of 3,687,500 securities from the JSE at approximately ZAR 16.13 per security.
  • The delisting aims to optimize the ETF's portfolio composition and enhance shareholder value, reducing the total number of SYGEMF securities in circulation to 142,235,965.
  • Investors advised to consult with financial advisors to understand implications of reduced supply and potential impact on liquidity and pricing dynamics of SYGEMF securities.

In a significant development today, Sygnia Itrix Collective Investment Scheme announced the partial delisting of securities for its flagship product, the Sygnia Itrix MSCI Emerging Markets 50 ETF (JSE Code: SYGEMF, ISIN: ZAE000297792). This move, effective immediately, is part of the ETF’s ongoing efforts to strategically manage its portfolio and maximize returns for investors.

With an approximate price of ZAR 16.13 per security, a total of 3,687,500 SYGEMF securities will be delisted from the Johannesburg Stock Exchange (JSE). This action is anticipated to optimize the ETF’s composition and enhance overall shareholder value. Following the partial delisting, the total number of SYGEMF securities in circulation will be reduced to 142,235,965.

The Sygnia Itrix MSCI Emerging Markets 50 ETF, managed by Sygnia Asset Management, is a registered portfolio within the Sygnia Itrix Collective Investment Scheme in Securities. Operating in accordance with the regulations outlined in the Collective Investment Schemes Control Act, 45 of 2002, the scheme offers investors exposure to a diversified portfolio of emerging market equities.

This partial delisting carries implications for investors and the broader market. By reducing the supply of securities, it is expected to generate increased demand, which could potentially impact the liquidity and pricing dynamics of SYGEMF securities. As a result, investors are advised to consult with their financial advisors or brokers to understand the implications and adjust their investment strategies accordingly.

Visited 1 times, 1 visit(s) today

Stay ahead in the financial world – Sign Up to Rateweb’s essential newsletter for free. Get the latest insights on business trends, tech innovations, and market movements, directly to your inbox. Join our community of savvy readers and never miss an update that could impact your financial decisions.

Do you have a news tip for Rateweb reporters? Please email us at


Start trading with a free $30 bonus

Trade stocks, forex, commodities, metals and CFDs on stock indices with an internationally licensed and regulated broker. For all clients who open their first real account, XM offers a $30 trading bonus without any initial deposit needed. Learn more about how you can trade over 1000 instruments on the XM MT4 and MT5 platforms from your PC and Mac, or from a variety of mobile devices.


Personal Financial Tools

Below is a list of tools built to assist South Africans to make the best financial decisions:



South Africa’s primary source of financial tools and information

Contact Us


Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.